
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 10.570 | 10.570 | 0.000 |
Shares | 89.760 | 89.760 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.599 | 22.347 |
Price to Book | 3.305 | 2.714 |
Price to Sales | 3.937 | 3.330 |
Price to Cash Flow | 15.022 | 16.400 |
Dividend Yield | 1.780 | 2.102 |
5 Years Earnings Growth | 4.540 | 6.822 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.980 | 97.797 |
Technology | 0.020 | 0.380 |
Number of long holdings: 49
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.15 | 58.76 | +1.78% | |
Kelun Pharm A | CNE100000PW7 | 7.19 | 35.47 | +1.37% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 6.73 | 99.11 | +0.10% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 6.63 | 321.04 | +6.70% | |
WuXi AppTec | CNE1000031K4 | 5.61 | 82.60 | +1.95% | |
APT Medical | CNE100004C45 | 5.47 | 289.98 | -0.39% | |
BeOne Medicines | CNE100005XT6 | 5.20 | 249.76 | -0.43% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 4.78 | 40.98 | +0.27% | |
Eyebright Medical Technology Beijing | CNE1000041J5 | 4.50 | 70.08 | +0.44% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 4.33 | 225.32 | +3.75% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIFM China Emerging Power Class A | 5.61B | 11.96 | -7.82 | 7.36 | ||
CIFM China Emerging Power Class H | 5.61B | 11.90 | -7.85 | - | ||
CIFM Technology Qian Yan Alloc | 2.63B | -0.67 | -8.81 | - | ||
China Intl AsiaPacific Advantage St | 2.41B | 11.97 | 8.04 | 5.69 | ||
China International China Advanced | 1.62B | 12.93 | -7.23 | 3.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review